Camille M. Selvais

<scp>AdipoRon</scp>, a new therapeutic prospect for Duchenne muscular dystrophy

Michel Abou‐Samra, Camille M. Selvais, Raphaël Boursereau et al. · Journal of Cachexia Sarcopenia and Muscle · 2020 · 46 citations · Full text

Medicine, Pharmacology, Cell Signaling +10

AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers

Camille M. Selvais, María A. Davis‐López de Carrizosa, Maxime Nachit et al. · Journal of Cachexia Sarcopenia and Muscle · 2022 · 30 citations · Full text

Medicine, Endocrinology, Physiology +17

Binding of matrilysin-1 to human epithelial cells promotes its activity

Alix Berton, Camille M. Selvais, Pascale Lemoine et al. · Cellular and Molecular Life Sciences · 2007 · 26 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +2

Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy

Nicolas Dubuisson, María A. Davis‐López de Carrizosa, Romain Versele et al. · Frontiers in Immunology · 2022 · 21 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +16

The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle

Nicolas Dubuisson, Romain Versele, María A. Davis‐López de Carrizosa et al. · Cells · 2023 · 13 citations · Full text

Medicine, Pharmacology, Physiology +13